May 14 & 15, 2021
CME-Accredited Online LIVE Broadcast Conference
ABOUT THE CONFERENCE
New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, the Leukemia & Lymphoma Society and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, 2-day educational conference. With an expanded agenda the conference is offering 8.5-hrs of continuing medical education. This is the eighth of these annual conferences that include programming for cancer clinicians.
<Register Today
CONFERENCE PLATFORM
The 2021 Spring to Life conference is being held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The sponsors and exhibitors of the conference will be available for attendees to visit during the duration of the conference in the Virtual Trade Show hall. The conference will be recorded and will be offered on-demand for 30 days following the conference.
PROGRAM OVERVIEW
New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, the Leukemia & Lymphoma Society and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, 2-day educational conference. With an expanded agenda the conference is offering 8.5-hrs of continuing medical education. This is the eighth of these annual conferences that include programming for cancer clinicians.
EDUCATIONAL GOAL
The purpose of this conference is to educate practitioners and update their knowledge of the biologic pathways associated with Leukemias and the existing and emerging therapies for the management of patients with leukemia.
TARGET AUDIENCE
The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family and primary care practitioner, allied health professional, and any other individuals with an interest in the care of patients with Leukemias.
LEARNING OBJECTIVES
After completing this activity, participants will be able to:
-
Describe the evolving gene mutational spectrum of malignant myeloid disease and the treatment paradigms of acute myeloid leukemia in the young fit and elderly or unfit populations
-
List the advances in biologic knowledge and treatments, including non-chemotherapy based treatments for acute lymphoblastic leukemia from young adults to the elderly
-
Review the current state of allogeneic hematopoietic stem cell transplantation in the curative treatment of acute leukemias
-
Discuss the shift in knowledge and treatment decision making in chronic lymphocytic leukemia and the management of chronic myeloid leukemia, including selecting for treatment-free remission
-
Explain the current knowledge on hematologic complications of COVID-19 and the data and contributors to outcomes disparities in Americans with hematologic malignancies
